ClinicalTrials.gg
Not yet recruitingNCT07186270Updated Sep 23, 2025

Decoding the Interplay of Front-of-Pack Labels, Price, and Consumer Perceptions: Impact on Food Choices in Korea and Singapore

An interventional study of Positively framed FOP labels (present versus absent) x Price (high versus low) and Graded FOP labels (no label vs. high rating (grade A) vs. low rating (grade D)) x Price (average vs. premium) in Consumer Behavior, sponsored by Duke-NUS Graduate Medical School. Not yet recruiting. Open to participants aged Up to 65 Years. Per ClinicalTrials.gov, last updated 2025-09-23.

Sponsored by Duke-NUS Graduate Medical School · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Randomized
Ages
Up to 65 Years
Sex
All
01

Study summary

The global epidemic of obesity and chronic diseases has led to widespread use of front-of-package (FOP) nutrition labels. While existing research has established a link between FOP labels and consumer choices, the interplay between product types, consumer perceptions, and label effectiveness is underexplored. This study examines: 1) whether consumers perceive healthier food item as more expensive when healthiness is less obvious; 2) how FOP labels mediate the relationship among product characteristics, price, and consumer's belief about food healthiness and price on choices; and 3) whether food choice changes given a price, with and without FOP labels, are more prominent for products where the perceived healthiness by consumers significantly differs from label indications. The investigators will conduct experiments with online panelists in Korea and Singapore in two settings: restaurant menus and grocery items. Results will inform more impactful nutritional information policies for healthier food choices and improved population health.

Read the detailed description

The investigators will conduct experiments in both Korea and Singapore, focusing on two settings with various food items: restaurant menu choices and grocery item selections. For each item, investigators will elicit consumers' prior belief about its healthiness. Our research builds upon the work of Haws et al. (2017), which demonstrated that US consumers tend to overgeneralize their belief about "expensive=healthy" to product categories where it is not true. This tendency potentially biases perceptions of healthy foods. The investigators aim to test this "expensive=healthy" intuition and its impact on food choice, with and without FOP labels, in Asian contexts. The investigators hypothesize that absent FOP labels, consumers will infer healthiness from price information (i.e., this product is expensive, so it must be healthy) and that providing FOP labels will reduce the reliance on this inference. The investigators also hypothesize that such effects of FOP labels are more prominent for products where the perceived healthiness by consumers significantly differs from the healthiness indicated by the labels. When the FOP labels show 'less healthy' for those expensive and perceived as 'healthy' products, consumers will update their prior belief about its healthiness and be more likely to drop the intuition 'expensive=healthiness' in decision-making and respond to a greater extent.

02

Conditions studied

  • Consumer Behavior

Browse trials for

Keywords

  • Front-of-pack labelling
03

In context

Consumer Behavior

43 studies on the registry are indexed under Consumer Behavior; 7 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 164 across 33 interventional studies indexed under Consumer Behavior.

Browse Consumer Behavior studies →

Lead sponsor

Duke-NUS Graduate Medical School is the lead sponsor of 63 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion criteria:

  • Adults aged 18-65 years residing in Korea
  • Adults aged 21-65 years residing in Singapore
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
1,000 participants (estimated)

Study arms

  • Experimental
    Study 1: Restaurant menu choice experiment

    Participants will read a hypothetical scenario about ordering a meal for a coworker. Participants will be told that their coworker has no dietary restrictions and is trying to eat healthier. They will be presented with two similar restaurant meal options, one priced higher than the other, with randomized assignments. In the label condition, a nutritional label for healthy foods, called the Healthy Choice Symbol adopted in Singapore, will be provided with an explanation of the labelling system. For both label and non-label conditions, participants will be asked to assess the healthfulness of each option using a standard 5-point scale (1-least healthy to 5-healthiest). Participants will then be asked to indicate which option to order for their coworker. Participants will be randomly assigned to one in four experimental arms.

    Behavioral: Positively framed FOP labels (present versus absent) x Price (high versus low)

  • Experimental
    Study 2: Grocery Food Item Choice Experiment

    Participants will read a hypothetical cover story about a new brand of a grocery item with generic health claims and see pictures of different flavors of this brand. Participants will be randomly assigned to either an average or a premium price condition and informed about the average price of other brands of the same item. They will be asked to indicate their perceived relative healthiness of the product compared to the products in other brands on a 5-point scale (1- least healthy to 5- healthiest). After assessment, they will see a high-grade label (grade A), low-grade label (grade D), or no label. For those exposed to labels, they will be given an explanation of the label and asked to indicate their perceived relative healthiness of the product again. In the end, all participants will indicate their intention to purchase items on a 7-point scale (1: least likely - 7: most likely). Participants will be assigned to one in six experimental arms.

    Behavioral: Graded FOP labels (no label vs. high rating (grade A) vs. low rating (grade D)) x Price (average vs. premium)

Interventions

  • BehavioralPositively framed FOP labels (present versus absent) x Price (high versus low)

    The intervention combines either a front-of-pack (FOP) label that frames high nutrition or no FOP label with price variation. Products are randomly assigned to either receive a positively-framed FOP label or no label, and to either a high or a low price. This yields four experimental arms: 1. Positively framed FOP label with high price 2. Positively framed FOP label with low price 3. No label with high price 4. No label with low price

  • BehavioralGraded FOP labels (no label vs. high rating (grade A) vs. low rating (grade D)) x Price (average vs. premium)

    The intervention combines either a graded front-of-pack (FOP) labelling or no FOP labelling with price variation. Products are randomly assigned to either receive a graded label or no label, and to either a premium or an average price. This yields six experimental arms: 1. High grade (A) with premium price 2. Low grade (D) with premium price 3. No label with premium price 4. High grade (A) with average price 5. Low grade (D) with average price 6. No label with average price

06

What researchers measure

Primary outcomes

  1. Consumers behavior

    Study 1: Participants achieve a response by choosing between two menu food items they would purchase for their co-worker in online experimental platform. Study 2: Participants rate their intention to purchase grocery items on a 7-point scale (1 = least likely, 7 = most likely) in online experimental platform.

    Time frame: Participants are expected to complete the online experiment in one sitting (within 24 hours). If they are disconnected from the survey platform, they are allowed up to two attempts to resume, with access to the platform disabled after 48 hours.

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2025; primary completion for Dec 2025, 2 months later.

Of 21 interventional studies with no phase under Consumer Behavior, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 14. This study's planned 2 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 11, 2025
First posted
Sep 22, 2025
StartEst.
Oct 2025
Primary completionEst.
Dec 2025
CompletionEst.
Dec 2025
Last update
Sep 23, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07186270
Lead sponsor
Duke-NUS Graduate Medical School
Collaborators
Korea University, National University of Singapore
Responsible party
Soye Shin (Assistant Professor, Duke-NUS Graduate Medical School) — Principal investigator
First posted
Sep 22, 2025
Start date
Oct 2025 (estimated)
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Sep 23, 2025

Study contacts

Soye Shin
Contact
syshin@duke-nus.edu.sg
+6566013319
Linh Nguyen
Contact
linhng@nus.edu.sg
+6590786645
Sang Hyeon Lee
principal investigator · Korea University
Soye Shin
principal investigator · Duke-NUS Graduate Medical School

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion